Valuing Value: Defining pharmaceutical value in 2024 - Life Science Access Academy

Masterclass Details:

At its core, the value proposition of pharmaceutical products is deeply entwined with their capacity to diagnose, treat and prevent diseases – a vital consideration in health technology appraisal (HTA).

In these assessments, a sharp focus is demanded on evidence demonstrating therapeutic value and economic benefits, with increasing focus on humanistic and societal value.

The innovation inherent in pharmaceuticals is also a focal point during these evaluations, reflecting the industry’s commitment to introducing novel therapies and treatment modalities that align with evolving healthcare needs.

Join us in this informative 60-minute masterclass for LSAA members and hear from experts at Initiate.

Key Learning Objectives:

Comprehend core components of pharmaceutical value proposition, including the capacity to diagnose, treat and prevent diseases
Gain a comprehensive understanding of the HTA process and its importance in evaluating pharma products
Explore the criteria and methodologies used in HTA to assess therapeutic value and economic benefits
Learn about the types of evidence required to demonstrate the therapeutic value of pharma products
Understand the growing emphasis on incorporating humanistic and societal values into HTA

Can’t make the date? Register and we’ll send you a link to the recording so you can watch it on demand in your own time.

Date and time

10th Sep 2024 13:00 – 14:00 (BST)

Book Now!

Valuing Value: Defining pharmaceutical value in 2024

Speakers

We work with more than 200 leading Life Sciences companies including:

Working with Life Science Access Academy, our company love the variety of the many courses that are on offer. The hour long courses on specific subjects are really useful on Friday lunchtimes for our field teams and gain a lot of interest.

Life Science Access Academy are also super flexible and helpful when it comes to tailoring some additional sessions to our needs.

Marsha Gray, Training Specialist

Boehringer Ingelheim Ltd

We have been partnered with LSAA for several years now which has enabled our team members to develop their competencies and capabilities.

With over 700 learning modules, regular webinars on highly relevant topics across the UK, the opportunity to engage with expert speakers after events and regular blogs and newsletters, the platform is a highly valued resource at Ferring.

The team also provides regular usage statistics so we can understand the hot topics in Ferring and enable colleagues to share knowledge and experience with each other.

Paul Runeckles, Director of Execution Excellence

Ferring

Frontier Medical has fully implemented, Life Science Access Academy allowing Sales and Marketing to utilise the system. Maximising on line learning for all remote staff stimulates a culture of self-development giving individuals the accountability and responsibility to broaden their skills set.

Life Science Access Academy training is topical and a good fit for the faced paced healthcare market.

Simon Warden, National Sales Manager

Frontier Medical Group

I have found the training via the Life Science Access Academy to be excellent and I know many of my colleagues have as well.

The content is always kept up to date and there is huge and interesting variety of topics covered. The site is curated in a way that makes it clear and easy to navigate. Also, the staff at Life Science access Academy are friendly and responsive and all the experts are always knowledgeable in their areas.

Richard Edmonds

Gedeon Richter Women's Health

The variety and relevancy of content brings value to many different roles across the healthcare industry.

I have also been overwhelmed by the way the Life Science Access Academy team have accommodated our own business needs, being sensitive yet responsive to helping us since its formation.

Robb Sayers, UK Capability Lead

ViiV Healthcare